Please tell us if you succeed in explaining them why they can’t do that 🙏
03.12.2025 05:35
👍 1
🔁 0
💬 0
📌 0
Please tell us if you succeed in explaining them why they can’t do that 🙏
Thanks to a funding from @fnr.lu 🙏
He will be coming next February. If you are around, please, come to the lecture.
I am happy for you to present it :)
What do you suggest when it is a common practice in some places ?
No. In the paper I read, they use multiple multivariable logistic regressions on 1000s potential exposures of an outcome, to identify those which remain significant at a very low p-value threshold. They do another multivariable analysis, and after something about Mendelian randomisation.
👋EpiBlueSky
There's an increasing interest in exposome-related research using GWAS methods. I'm not an expert & not a fan of data-driven approaches, which look like p-fishing exercises.
Does anyone know a resource which criticises these approaches or convinces me that they're good?
🙏
Enjoy and say hello to @pwgtennant.bsky.social :)
Happy International Nurses Day!
Today, we honour nurses in #GeriatricOncology — leaders in care, clinical expertise, & research.
From assessments to symptom relief, coordination to end-of-life support, and advancing knowledge through research — your role is essential.
💙 Thank you for all you do.
The absence of ego 😁
Not sure how to describe me if you were stupid 😬 You are very far from being stupid.
Not here 🤔 It seems that it is more a technical issue than a political shut down.
Not fully there yet ! But this was temporary ! This is a relief 🥲
Pubmed is down ! That is unbelievable 😨
Happy that our piece to present the @siogorg.bsky.social Methods Working Group I co-created with Dr Jennifer Lund is out 👇🏻
www.sciencedirect.com/science/arti...
Putting the finishing touches on a grant proposal—only to realise that a recently published paper is strikingly similar to what I had planned to propose!
Happy to see this published! I had been thinking of writing something similar when I found the time.
For all researchers working with quantitative data, this is a must-read 👇
Now I finally have a ref to attach to all my peer reviews! 😊https://www.neurology.org/doi/10.1212/WNL.0000000000210171
@fnr.lu @siog-nahs.bsky.social @siogorg.bsky.social
The 1st ACADI newsletter is out 😀 Have a read 👇🏻
Thanks to Dr India Pinker for the design 🙏
www.lih.lu/en/article/a...
I know about the residual confounding at T0. It was more about the Daggitty comment I was worried about. Thank you for your help. Hope you are doing well :)
Actually, a bit more complicated than that. But basically observed only at T1. I tried with observed/unobserved etc still incorrectly adjusted.
Observed at T1 but not observed at T0.
#DAGsaddict
👋 Need help!
Is there a way I can estimate the causal effect of sleep on cancer risk in the scenario below?
DAGITTY tells me "Incorrectly adjusted" when adjusted on lifestyle factors at T-1 and T0.
🙏
Grant rejected 😞
Have to wait to know why.
On #WorldCancerDay, we highlight the unique cancer challenges older adults face & the need for better representation in research. Aligned w/ #UnitedbyUnique, ACADI advocates for person-centred oncology & equitable care. #CloseTheCareGap #GeriatricOncology
🙏 to India Pinker for designing this post!
Dry January ✅
Now starting Dry February !
TIP: If you're planning a comparative effectiveness study in observational data, particularly a target trial emulation study, then please pre-register a study protocol!
It makes a huge difference to how much readers will trust (or doubt) the analytical choices and results.
#EpiSky
I like it :) Thanks for sharing.
Seems super interesting but seems available in btw 3-7 months in France 🤪
